What they were paid
Artiva Biotherapeutics Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $28,410 | — | $0 | — | $28,410 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Artiva Biotherapeutics, Inc. DEF 14A filed August 3, 2026, accession 0001193125-26-330563, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Artiva Biotherapeutics pays directors a $40,000 cash retainer.
The rest of the Artiva Biotherapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Alison Moore, Ph.D | Independent Director | $71,390 |
| Brian Daniels, M.D | Independent Director | $117,357 |
| Daniel Baker, M.D | Independent Director | $180,527 |
| Diego Miralles, M.D | Independent Director | $71,390 |
| Elaine Sorg | Independent Director | — |
| Elizabeth Hougen | Independent Director | $71,390 |
| Fred Aslan, M.D | Director | $0 |
| Laura Stoppel, Ph.D | Independent Director | $71,249 |
The full Artiva Biotherapeutics compensation record
free company briefThis page is one director within Artiva Biotherapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat